AXT, Inc. Form 8-K Summary
Business Context and Reporting Period
AXT, Inc. (NASDAQ: AXTI), a Delaware corporation, filed this Current Report on Form 8-K on December 29, 2025. The filing details the entry into a material definitive agreement for a public offering of common stock and the subsequent full exercise of the underwriters' over-allotment option.
Key Financial Metrics and Transaction Details
- Offering Price: $12.25 per share.
- Base Shares: 7,098,492 shares.
- Option Shares (Over-Allotment): 1,064,773 shares (fully exercised).
- Total Shares Sold: 8,163,265 shares.
- Gross Proceeds (Base): Approximately $87 million.
- Gross Proceeds (Option): Approximately $13.04 million.
- Total Expected Gross Proceeds: Approximately $100 million (before underwriting discounts and expenses).
- Underwriters: Northland Securities, Inc. (Sole Bookrunner); Wedbush Securities Inc. and Craig-Hallum Capital Group LLC (Co-managers).
Material Changes and Events
The primary material event is the completion of a capital raise. On December 29, 2025, the underwriters exercised the 30-day option to purchase all 1,064,773 additional shares. This action increases the total capital raised from the base offering amount to the maximum potential amount of approximately $100 million in gross proceeds. The offering is anticipated to close on December 30, 2025.
Use of Proceeds, Guidance, and Risks
Use of Proceeds: The Company intends to use net proceeds to financially support its subsidiary, Beijing Tongmei Xtal Technology Co., Ltd., specifically to increase capacity for producing indium phosphide substrates for export. Additional uses include research and development of new products, working capital, and general corporate purposes.
Lock-Up Agreement: Executive officers and directors have agreed to a 60-day lock-up period from the date of the prospectus supplement, restricting the disposal or hedging of Company securities.
Risks and Contingencies: The filing notes that the Underwriting Agreement contains customary representations, warranties, indemnification obligations, and termination provisions. The filing explicitly states it does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts, commissions, and offering expenses.
- Confirm the exact closing date of the transaction (anticipated December 30, 2025).
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific covenants and termination rights.
- Monitor the press release (Exhibit 99.1) for any additional commentary on market conditions or strategic shifts.
- Check subsequent filings for the actual allocation of funds to the Beijing Tongmei subsidiary.